Oscient Pharmaceuticals Corporation to Participate in the Natixis Bleichroeder Hidden Gems Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) will participate in the Natixis Bleichroeder Hidden Gems Conference on Monday, October 8, 2007 in New York City. The Company’s President and CEO, Steven Rauscher, will provide an overview of the Company including details on the recent market performance of ANTARA® (fenofibrate) capsules and FACTIVE® (gemifloxacin mesylate) tablets in the U.S. The presentation will begin at 11:30 AM ET on Monday and will be webcast through the Company’s website at www.oscient.com. An archive of the webcast will also be available for 90 days.

MORE ON THIS TOPIC